D.E. Shaw & Co
RXST icon

D.E. Shaw & Co’s RxSight RXST Stock Holding History

D.E. Shaw & Co’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,400
Closed -$267K – 4805
2024
Q3 		$267K Sell
5,400
-2,300
-30% -$118K ﹤0.01% 4032
2024
Q2 		$463K Buy
+7,700
New +$440K ﹤0.01% 3665

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

D.E. Shaw & Co's RXST Position: Q2 2026 in Review

D.E. Shaw & Co increased its RxSight (RXST) stake by 1.3% in Q2 2026, buying an estimated $154K and bringing the position to 1,985,215 shares worth $9.57M. The position accounts for ﹤0.01% of the portfolio, ranked #1848.

D.E. Shaw & Co first reported a position in RXST in Q2 2023 and has held it in 13 quarters since. The position peaked at $19.6M in Q4 2025. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • D.E. Shaw & Co held 1,985,215 shares of RxSight worth $9.57M as of Q2 2026.
  • D.E. Shaw & Co bought 25,483 RxSight shares in Q2 2026, an estimated $154K.
  • RxSight made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #1848 holding.
  • D.E. Shaw & Co first reported a position in RxSight in Q2 2023 and has held it in 13 quarters since.
  • D.E. Shaw & Co's RxSight position peaked at $19.6M in Q4 2025.
  • 152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.